$BLMN, $MRVL, $MEIP, $PPL, $UNFI, $WSM

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Monday, 1 June, as follows:

Bloomin’ Brands Inc. (NASDAQ:BLMN) was raised to Buy from Hold and the price target was raised to 16 from 12 at Jefferies.

Marvell Technology Group Ltd. (NASDAQ:MRVL) was reiterated as Buy and its price target was raised to 34 from 28 at Needham. Morgan Stanley reiterated it as Equal Weight and raised its price target to 33 from 25. B Riley FBR reiterated its Buy rating and raised its price target from 34 to 38.

MEI Pharma Inc. (NASDAQ:MEIP) was started with a Buy rating and a 16 price target SunTrust Robinson Humphrey. As this is an exponential upside call, the firm sees it having a best-in-class PI3Kδ inhibitor, which has demonstrated strong risk-benefit profile in Phase 1 lymphoma trials.

PPL Corp. (NYSE:PPL) was raised to Buy from Neutral with a 30 price target at Mizuho.

United Natural Foods Inc. (NYSE:UNFI): distribution to grocery stores is a hot business in a lockdown environment. Shares recently closed at 18.15, with a consensus price target of 10.50.

Williams-Sonoma Inc. (NYSE:WSM) was reiterated as Buy and its price target was raised to 90 from 45 at CFRA. Shares were at 83.21 Friday after crushing earnings estimates due to online sales while its stores were closed.

Have a healthy week, Keep the Faith!

  analysts, avoid, BLMN, buy, heffx, hold, MEIP, MRVL, PPL, sell, trade, UNFI, Wall Street, WSM

The following two tabs change content below.

• Bio
• Latest Posts

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   

Latest posts by Paul Ebeling (see all)

• Commentary: Paul Ebeling on Wall Street, Investors Look Past the COVID Chaos - November 30, 2020
• Wall Street’s Key Stock Analysts Research Report, All Buys - November 30, 2020
• Monday’s World Stock Markets: Asia-Pacific - November 30, 2020